Dotbee.ai

Analysis Longboard Pharmaceuticals, Inc. (LBPH)

5/27/2024

Analysis Longboard Pharmaceuticals, Inc. (LBPH)

Analysis of Longboard Pharmaceuticals, Inc. (LBPH)

Longboard Pharmaceuticals, Inc. (LBPH) has shown some interesting price movements and technical indicators in the past few days:

1. **Price Movement**: The stock price has been fluctuating between $18.41 and $21.79 over the past week, with the closing price on the latest trading day at $18.80. This indicates some volatility in the stock.

2. **Relative Strength Index (RSI)**: The RSI indicator has been hovering around 40-50, indicating a neutral sentiment in the market. It currently stands at 41.56, suggesting that the stock is neither overbought nor oversold.

3. **Moving Average Convergence Divergence (MACD)**: The MACD line has been crossing below the signal line, with the MACD histogram showing negative values. This could indicate a bearish trend in the stock price.

4. **Moving Averages (MA)**: The Simple Moving Average (SMA) and Exponential Moving Average (EMA) are close to each other, indicating a consolidation phase in the stock price. The Weighted Moving Average (WMA) is slightly higher, suggesting a slightly bullish bias.

Overall, Longboard Pharmaceuticals, Inc. seems to be in a consolidation phase with a neutral sentiment in the market. Traders and investors may want to closely monitor the MACD indicators for potential trend reversals in the coming days.

Earnings

The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released After Hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.

Main Statystic 🧠

The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.

In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.44.

Moving on to stock statistics, the company has a short ratio of 1.66, with 15.31 billion float shares and 94.31 million shares shorted. The stock has outstanding shares of 15.33 billion, with 5.22% held by insiders and 57.55% held by institutions. The short percent of shares outstanding is 0.62%.

Valuation metrics show a PEG ratio of 26.21, forward PE of 26.21, and trailing PE of 29.43. The enterprise value is $2.95 trillion, with a price to book ratio of 39.18 and price to sales ratio of 7.62. The enterprise to EBITDA ratio is 22.75 and enterprise to revenue ratio is 7.73. The market capitalization stands at $2.91 trillion.

The stock price summary includes a beta of 1.26, 50-day moving average of $173.69, 200-day moving average of $180.79, a 52-week low of $164.08, a 52-week high of $199.62, and a 52-week change of 8.25%.

Lastly, dividends and splits information shows a payout ratio of 14.93%, with a dividend date of May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split factor. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a forward annual dividend yield of 0.53%. The trailing annual dividend rate is $0.97, with a trailing annual dividend yield of 0.51%.

Income statement 💸

These are the revenue figures. Here are the conclusions:

1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been fluctuating, with a peak in 2021 at $152.8 billion and a peak in 2023 at $169.1 billion.
3. Operating income has also been on the rise, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has shown a similar upward trend, increasing from $57.4 billion in 2020 to $97 billion in 2023.
5. Earnings per share (EPS) have been increasing slightly, with diluted EPS at $3.28 in 2020 and $6.13 in 2023.
6. The company has been able to maintain a consistent number of outstanding shares over the years, indicating stability in this aspect.
7. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving over the years.

Balance Sheet

These are balance sheets. Here are the conclusions:

1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been increasing over the years, with the highest value in 2018 at $107,147,000,000.

Cash Flow 💶

This is the cash flow statement. Here are some conclusions we can draw from the data:

1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show significant fluctuations, especially in common stock repurchases and long-term debt issuuance.
5. Investing activities also vary, with notable amounts spent on the sale and purchase of investments.
6. The end cash position has been fluctuating, reaching its highest value in 2020 and its lowest in 2022.
7. The company has been paying dividends to common shareholders, with varying amounts each year.
8. Stock-based compensation has also been fluctuating, indicating changes in employee compensation strategies.
9. Overall, the company's financial performance and cash flow management have shown variability over the years, with some key trends and patterns emerging.

Earnings estimate

Based on analysts' estimates for future quarterly and annual earnings per share:

1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.33, with a low estimate of $1.27 and a high estimate of $1.36. This shows growth compared to the EPS of $1.26 from the same quarter a year ago.

2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.53, with a low estimate of $1.44 and a high estimate of $1.63. This indicates an increase from the EPS of $1.46 from the same quarter last year.

3. For the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.59, with a low estimate of $6.43 and a high estimate of $6.92. This reflects growth compared to the EPS of $6.13 from the previous fiscal year.

4. Looking ahead to the next fiscal year ending on September 30, 2025, the average EPS estimate is $7.23, with a low estimate of $6.40 and a high estimate of $7.90. This suggests an increase from the EPS of $6.59 reported for the fiscal year ending in 2024.

Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for both the upcoming quarters and fiscal years.

Revenue estimate

Based on the analysts' estimates for the future quarterly and annual sales of the company, the following conclusions can be drawn:

1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.

2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.

3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.

4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.

Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.

Growth estimates

Based on the consensus estimates provided:
- The company is expected to experience a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is projected to be 4.8%.
- Over the next 5 years, the company is expected to achieve an annual growth rate of 11%.
- In the past 5 years, the company has achieved an annual growth rate of 20.15%.

Overall, the company is expected to maintain a positive growth trajectory, with a higher growth rate projected for the future compared to the current and past performance.

Price target

The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD

Based on these forecasts, it seems that the analysts are generally optimistic about the future price of the security, with a median and average price above the current price. However, there is a wide range between the low and high forecasts, indicating some uncertainty or differing opinions among analysts.

MACD of LBPH

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link